Conference Summary

This FASEB Science Research Conference (SRC) began in 1991 and has explored the forefront of research into the biochemical and medical importance of small GTPases, such as the RAS and RHO family proteins.

The conference allows for interactions between basic, translational, and clinical scientists in both academia and industry, who study everything from basic biology to therapeutic aspects of small GTPases.

Central themes of the conference are: 1) Explore the most exciting strategies to therapeutically target small GTPases involved in the pathogenesis of cancer, neurodegeneration, and other diseases; 2) Discuss recent advances in our understanding GTPase molecular regulation, posttranslational modification, and effector interactions; 3) Develop new technological platforms for studying and visualizing GTPases in vitro and in vivo.

The conference sessions will cover the latest research and foster lively discussions on:

  • Targeting Ras and other small GTPases in cancer
  • Emerging technologies in small GTPase analyses
  • Regulation of small GTPase signaling and effector protein interactions
  • Structural aspects of small GTPase signaling
  • GTPase posttranslational modifications and compartmentalized signaling
  • Small GTPases in neuronal development and degenerative diseases
  • Small GTPase control of cell adhesion, migration, and invasion

In addition to an opening keynote lecture from Douglas Lowy, MD (National Cancer Institute), the conference will feature eight oral sessions, two poster sessions, and a career development section, "Practical Tips for a Winning Grant Proposal."

We welcome you to participate in lively discussions on these topics in a relaxed collegial atmosphere.

Registration Prices

    Sign Up for Emails


    Conference Location

    St. Bonaventure University
    Francis Hall Building
    Clare Road
    Olean, NY 14760 USA

    Conference Organizers

    Martin Bergo, PhD
    Professor and Investigator, Molecular Medicine, Department of Biosciences and Nutrition, Karolinska Institutet, and Member of the Nobel Assembly, Stockholm, Sweden

    Sharon Campbell, PhD
    Liebscher Distinguished Professor and Investigator, Department of Biochemistry and Biophysics, and Member, Lineberger Cancer Center, University of North Carolina, Chapel Hill, USA

    Keynote Speaker

    Douglas Lowy, MD
    National Cancer Institute



    Platinum Supporters